Eagle Meds Services
VITRAKVI (LAROTRECTINIB)
Available to sourceHuman Prescription DrugOncology & Specialty

VITRAKVI (LAROTRECTINIB)

25 mg/1 · Capsule
By Bayer HealthCare Pharmaceuticals Inc.
NDC
50419-390
Route
Oral
Therapeutic class
Kinase Inhibitor , Tropomyosin Receptor Kinases Inhibitors [MoA]
Marketing category
NDA

Package sizes

  • 60 CAPSULE in 1 BOTTLE (50419-390-01)NDC 50419-390-01Available to order

Additional information

Full prescribing information for this product is available on request. Submit a sourcing request and our team will share lot details, dating, and current pricing.

Request this medication

Send a request and we'll respond with availability, lot details, and pricing within 2 business hours.

Requesting
VITRAKVI (LAROTRECTINIB)
NDC 50419-390